Dog Aging Project

Project Results & Usefulness

• Some argue the project has spent tens of millions and hasn’t yet produced practical improvements in human quality of life, which they see as its stated goal.
• Others counter that the publication list is substantial and that “negative” or non‑translatable findings are still valuable science.
• A few participants note that extending dogs’ healthy lifespan directly improves owners’ quality of life, even if human translational impact is limited or delayed.

Veterinary–Human Medicine Links

• Examples cited where animal work informed human health: malaria parasite discovery from cattle research, transmissible spongiform encephalopathies (scrapie → kuru), retroviruses in cattle preceding HIV/AIDS, and dog cancer as a mid‑step between mouse and human trials.
• Another view points to methodological limits and publication bias in animal research, casting doubt on how reliably it transfers to humans.

Website & Participant Experience

• Many complain the site “scrolljacks,” is JS‑heavy, and breaks normal scrolling on desktop and mobile.
• One former participant reports clunky UI and long, frequent surveys, leading to doubts about the project’s methodology.

Rapamycin & Dog Longevity Trials

• Joining certain arms makes a dog a research subject for rapamycin/sirolimus.
• Commenters describe it as an mTOR inhibitor with immune‑modulating and immunosuppressive side effects; some say initial promise for aging now looks “less likely,” others remain open‑minded.
• Ethical stance: risks exist, but potential healthspan benefits for dogs (and possibly humans) justify careful trials.

Fraud, Funding, and Presentation

• Some readers’ “fraud alarms” are triggered by the slick, consumer‑oriented site and emotional framing around pets.
• Others push back, noting university affiliation, large visible team, free participation (DNA kits covered), and a publications list.
• There is disagreement over whether the main risk is actual financial fraud, misaligned priorities, or simply aesthetic distrust due to marketing‑style design and donation asks.

Broader Aging & Longevity Debate

• Several distinguish between lifespan and healthspan, supporting efforts to extend healthy years rather than chasing immortality.
• Critics worry about social consequences of longer lives: wealth accumulation, reduced turnover of cultural/scientific elites, and possible exacerbation of inequality.
• Supporters argue longer healthy lives may encourage longer‑term thinking and are ethically similar to any other medical advance.